Siren, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002005245

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2025 · 110 positions · Total reported value $1.93B · Top-10 concentration 48.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.7% · 15 new · 36 cut · 22 exited

Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Siren, L.L.C. disclosed 110 equity positions with a combined reported value of $1.93B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were SRRK ($327.64M), KYMR ($149.60M), ONC ($123.45M). By sector, the heaviest allocations are Health Care 74.1%, Technology 6.9%. Versus the prior quarter, allocation shifted toward Health Care (+6.5pp) and away from Other (-5.9pp).

Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q2 2025 were MLTX ($23.99M), AKRO ($17.00M), AVBP ($15.24M).

Of the 22 positions fully exited versus the prior quarter, the largest were BPMC ($64.27M), PRTA ($15.88M), SMMT ($13.41M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $23.99M
  • AKRO AKERO THERAPEUTICS INC · $17.00M
  • AVBP ARRIVENT BIOPHARMA INC · $15.24M
  • COGT Cogent Biosciences, Inc. · $6.13M
  • PCRX PACIRA BIOSCIENCES INC · $5.38M
  • HUBS HUBSPOT INC · $1.67M
  • UNH UNITEDHEALTH GROUP INC · $1.58M
  • GTLB GitLab Inc. · $1.58M

Fully Exited (vs previous quarter)

  • BPMC BLUEPRINT MEDICINES CORP · prev qtr: $64.27M
  • PRTA PROTHENA CORP PLC · prev qtr: $15.88M
  • SMMT SUMMIT THERAPEUTICS INC · prev qtr: $13.41M
  • MTSR METSERA INC · prev qtr: $4.08M
  • LPLA LPL FINL HLDGS INC · prev qtr: $2.45M
  • MRVL MARVELL TECHNOLOGY INC · prev qtr: $2.27M
  • SARO STANDARDAERO INC · prev qtr: $1.51M
  • BILL BILL HOLDINGS INC · prev qtr: $1.31M

Insider Transactions (Form 4)

Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).

Portfolio Structure

  • 116 positions · $4.93B reported value (Q2 2026)
  • Top 10 holdings = 44.8% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
  • Average position size: $42.48M

Sector Tilt

  • Health Care 92.0%
  • Information Technology 4.5%
  • Consumer Discretionary 1.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
  • 38 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 74.1%
Technology 6.9%
Financials 0.1%
Other 16.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 9.25M $327.64M 16.95%
16.95%
Hold
2 3.43M $149.60M 7.74%
7.74%
Add
3 509.99K $123.45M 6.39%
6.39%
Add
4 1.10M $58.22M 3.01%
3.01%
Add
5 1.69M $48.56M 2.51%
2.51%
Hold
6 5.22M $48.47M 2.51%
2.51%
Add
7 4.84M $46.04M 2.38%
2.38%
Add
8 3.46M $45.46M 2.35%
2.35%
Add
9 853.47K $44.89M 2.32%
2.32%
Reduce
10 2.58M $44.63M 2.31%
2.31%
Hold
11 245.94K $42.45M 2.20%
2.20%
Reduce
12 2.67M $42.18M 2.18%
2.18%
Hold
13 3.16M $41.43M 2.14%
2.14%
Add
14 467.34K $39.15M 2.03%
2.03%
Reduce
15 38.92M $36.81M 1.91%
1.91%
Hold
16 9.97M $36.49M 1.89%
1.89%
Hold
17 7.42M $36.12M 1.87%
1.87%
Hold
18 938.75K $34.54M 1.79%
1.79%
Add
19 1.11M $31.54M 1.63%
1.63%
Hold
20 409.74K $25.89M 1.34%
1.34%
Add
21 594.99K $25.84M 1.34%
1.34%
Hold
22 2.25M $25.51M 1.32%
1.32%
Hold
23 11.01M $25.44M 1.32%
1.32%
Add
24 812.76K $25.44M 1.32%
1.32%
Add
25 3.70M $24.03M 1.24%
1.24%
Hold
26 508.27K $23.99M 1.24%
1.24%
New
27 2.20M $23.28M 1.21%
1.21%
Hold
28 1.19M $21.63M 1.12%
1.12%
Reduce
29 3.94M $21.55M 1.11%
1.11%
Add
30 3.36M $17.23M 0.89%
0.89%
Add
31 318.65K $17.00M 0.88%
0.88%
New
32 2.91M $16.89M 0.87%
0.87%
Add
33 700.00K $15.24M 0.79%
0.79%
New
34 2.01M $13.99M 0.72%
0.72%
Add
35 1.61M $13.12M 0.68%
0.68%
Hold
36 2.36M $13.11M 0.68%
0.68%
Hold
37 56.50K $12.40M 0.64%
0.64%
Hold
38 821.51K $11.49M 0.59%
0.59%
Hold
39 8.76M $11.12M 0.58%
0.58%
Hold
40 1.01M $10.23M 0.53%
0.53%
Hold
41 515.45K $9.67M 0.50%
0.50%
Add
42 295.54K $9.61M 0.50%
0.50%
Hold
43 18.50K $9.42M 0.49%
0.49%
Reduce
44 1.19M $8.99M 0.47%
0.47%
Hold
45 50.70K $8.93M 0.46%
0.46%
Hold
46 788.45K $8.66M 0.45%
0.45%
Hold
47 4.00M $8.56M 0.44%
0.44%
Hold
48 16.15K $8.03M 0.42%
0.42%
Reduce
49 49.98K $7.90M 0.41%
0.41%
Add
50 170.00K $7.30M 0.38%
0.38%
Hold

FAQ

What did Siren, L.L.C. buy in 2025-Q2?

In its 2025-Q2 13F filing, Siren, L.L.C. reported 110 equity positions worth $1.93B in aggregate; its largest disclosed positions were SRRK ($327.64M), KYMR ($149.60M), ONC ($123.45M).

How large is Siren, L.L.C.'s portfolio?

Siren, L.L.C. reported $1.93B of long equity holdings across 110 positions as of 2025-Q2. Top-10 holdings account for 48.5% of reported value.

What is Siren, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/siren/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →